Your browser doesn't support javascript.
loading
CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy.
Khan, Tashbib; Lyons, Nicholas J; Gough, Madeline; Kwah, Kayden K X; Cuda, Tahleesa J; Snell, Cameron E; Tse, Brian W; Sokolowski, Kamil A; Pearce, Lesley A; Adams, Timothy E; Rose, Stephen E; Puttick, Simon; Pajic, Marina; Adams, Mark N; He, Yaowu; Hooper, John D; Kryza, Thomas.
Afiliação
  • Khan T; Mater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, Australia.
  • Lyons NJ; Mater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, Australia.
  • Gough M; Mater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, Australia.
  • Kwah KKX; Mater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, Australia.
  • Cuda TJ; Mater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, Australia.
  • Snell CE; Mater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, Australia.
  • Tse BW; Mater Health Services, South Brisbane, QLD, Australia.
  • Sokolowski KA; Preclinical Imaging Facility, Translational Research Institute, Woolloongabba, QLD, Australia.
  • Pearce LA; Preclinical Imaging Facility, Translational Research Institute, Woolloongabba, QLD, Australia.
  • Adams TE; Commonwealth Scientific and Industrial Research Organisation Manufacturing, Parkville, VIC, Australia.
  • Rose SE; Commonwealth Scientific and Industrial Research Organisation Manufacturing, Parkville, VIC, Australia.
  • Puttick S; Commonwealth Scientific and Industrial Research Organisation, Herston, QLD, Australia.
  • Pajic M; Commonwealth Scientific and Industrial Research Organisation, Herston, QLD, Australia.
  • Adams MN; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Faculty of Medicine, St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.
  • He Y; School of Biomedical Sciences, Centre for Genomics and Personalised Health, Queensland University of Technology, Brisbane, QLD, Australia.
  • Hooper JD; Mater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, Australia.
  • Kryza T; Mater Research Institute - The University of Queensland, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, Australia.
Theranostics ; 12(16): 6915-6930, 2022.
Article em En | MEDLINE | ID: mdl-36276654
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Colon_e_reto Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Imunoconjugados / Antineoplásicos Tipo de estudo: Diagnostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Theranostics Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Colon_e_reto Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Imunoconjugados / Antineoplásicos Tipo de estudo: Diagnostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Theranostics Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália